Serial #79201619
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79201619 Trademark

Serial Number: 79201619 • Registration: 5537623

Serial #79201619 is a trademark filed by EUROIMMUN Medizinische Labordiagnostika AG on August 18, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

EUROIMMUN Medizinische Labordiagnostika AG

Seekamp 31
Lübeck 23560 , DE

Entity Type: 25

Trademark Details

Filing Date

August 18, 2016

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Goods & Services

Scientific, surveying, photographic, optical, measuring and control apparatus and instruments, namely, Fluorescence microscopes; [ Cameras; ] Scanners for diagnostics, namely, flatbed scanners, drum scanners and hand-held scanners for reading images from medical devices, blots, line blots, dot blots, microtiter plates, and microscopy slides for laboratory and research use; [ Photometers; Mass spectrometers; Bar code readers; ] Diagnostic apparatus for the profiling of antibodies, antigens and nucleotides for laboratory or research use; [ polymerase chain reaction thermocyclers for nucleotide amplification for laboratory and research purposes; immunoassay staining devices; immunoassay staining instruments; Analytical apparatus, namely, an automated slide stainer for use in medical laboratories; ] Laboratory equipment and supplies, namely, incubators and incubator trays for laboratory or research purposes; Constant temperature incubators for laboratory use; [ Constant humidity incubators for laboratory use; ] Laboratory equipment and supplies, namely, washing trays for laboratory or research purposes; [ Incubators for bacteria cultures; ] Chemiluminescence detectors for use in protein and nucleotide research for laboratory or research purposes; [ fluorescence detector for crime scene investigations; ] fluorescence detector for diagnosis of neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer, for laboratory or research purposes; [ furniture especially made for laboratories; calculators; computer hardware for data processing; Computer hardware for high-speed processing and storage of data; ] Computer [ hardware and ] software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Computers; computer software for running a fluorescence [ or nuclear ] medicine diagnostic imaging apparatus and evaluating diagnostic assays; CDs featuring [ movies, films, audiobooks, music, diagnostic data and ] device manuals

Chemical preparations for commercial, scientific and photographic purposes, namely, Biological tissue cultures, other than for medical or veterinary purposes; [ Biological tissue cultures, other than for medical or veterinary purposes, on glass slides; ] Biological tissue, namely, mammalian tissue and cells for use in scientific and medical research; Biological tissue, namely, blood [ , stem cells, umbilical cords and placentas ] for scientific and medical research use; [ Biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; ] Chemical and biological reagents, namely, Reagents for use in scientific apparatus for chemical or biological analysis; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use other than for medical or veterinary purposes; Monoclonal antibodies for in vitro scientific or research use; Protein for industrial use; Protein in raw material form for scientific and medical research; Protein arrays and nucleotide arrays for scientific and medical research; Proteins for use in manufacture; Proteins for the food industry; diagnostic reagents, namely, virus for in vitro scientific or research use; diagnostic reagents, namely, flavivirus for in vitro scientific or research use; Nucleic acid for laboratory use; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Biological preparation for use in cell cultures other than for medical or veterinary use; Cells for scientific and research use

[ Diagnostic preparations for pharmaceutical, medical and veterinary purposes, namely, Ovulation test kits; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; ] Diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurological diseases, autoimmune diseases, infectious diseases, allergies; Biochips, namely, [ glass or ] plastic carriers with protein, tissue, cells or antigen used for medical diagnostics; Blots, namely, carriers coated with diagnostic reagents for medical use; Line blots, namely, carriers coated with diagnostic reagents for medical use; Dot blots, namely, carriers coated with diagnostic reagents for medical use; Microtiter plates, namely, carriers coated with diagnostic reagents for medical use; Medical diagnostic test strips for use in the field of neurological diseases, autoimmune diseases, infectious diseases, allergies; Medical diagnostic test strips for blood, urine and liquor analysis

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 9, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 9, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 2, 2025 APRE
TEAS SECTION 71 RECEIVED
Feb 14, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 14, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 1, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 1, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 1, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 14, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
May 30, 2018 CORR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION PROCESSED BY IB
May 25, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 9, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 9, 2018 OP2R
EXPARTE APPEAL TERMINATED
Apr 25, 2018 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 25, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 25, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 25, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 25, 2018 CNEA
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 19, 2018 CRCV
EX PARTE APPEAL-INSTITUTED
Mar 23, 2018 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 23, 2018 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Mar 23, 2018 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 27, 2018 ERFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2018 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 25, 2017 GNFN
FINAL REFUSAL E-MAILED
Sep 25, 2017 GNFR
FINAL REFUSAL WRITTEN
Sep 25, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2017 CRFA
ASSIGNED TO LIE
Aug 29, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2017 TROA
REFUSAL PROCESSED BY IB
Mar 25, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2017 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Feb 21, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2017 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 16, 2017 REPR